衰老
端粒
癌变
癌症
DNA损伤
癌症研究
癌细胞
生物
细胞周期检查点
效应器
细胞周期
肿瘤进展
细胞生长
细胞生物学
DNA
生物化学
遗传学
作者
Wiktoria Monika Piskorz,Marzanna Cechowska‐Pasko
标识
DOI:10.3390/ijms231911082
摘要
Cellular senescence process results in stable cell cycle arrest, which prevents cell proliferation. It can be induced by a variety of stimuli including metabolic stress, DNA damage, telomeres shortening, and oncogenes activation. Senescence is generally considered as a process of tumor suppression, both by preventing cancer cells proliferation and inhibiting cancer progression. It can also be a key effector mechanism for many types of anticancer therapies such as chemotherapy and radiotherapy, both directly and through bioactive molecules released by senescent cells that can stimulate an immune response. Senescence is characterized by a senescence-associated secretory phenotype (SASP) that can have both beneficial and detrimental impact on cancer progression. Despite the negatives, attempts are still being made to use senescence to fight cancer, especially when it comes to senolytics. There is a possibility that a combination of prosenescence therapy-which targets tumor cells and causes their senescence-with senotherapy-which targets senescent cells, can be promising in cancer treatment. This review provides information on cellular senescence, its connection with carcinogenesis and therapeutic possibilities linked to this process.
科研通智能强力驱动
Strongly Powered by AbleSci AI